Related Experiment Video
Updated: Dec 4, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Potassium overdose using an oral solution: Potassium element expressed in grams as a packaging flaw contributing to
B Charpiat1, L Veremme1, B Duriez2
1Service pharmacie, hospices civils de Lyon, hôpital de la Croix-Rousse, 69004 Lyon, France.
Medication packaging flaws can cause dangerous drug errors. Standardizing dosage units to millimoles on packaging and prescriptions can prevent potassium double dosing and improve patient safety.
Area of Science:
- Pharmaceutical Sciences
- Patient Safety
- Medication Error Research
Background:
- Drug packaging design significantly impacts patient safety and treatment outcomes.
- Inadequate packaging can lead to medication misuse, with potentially severe health consequences.
Purpose of the Study:
- To report a specific medication error involving a potassium double dose.
- To identify the packaging flaw that triggered the error.
- To propose a standardization solution to prevent future errors.
Main Methods:
- Case report of a potassium double dose medication error.
- Analysis of drug packaging design and dosage indication.
- Review of medication error causes related to packaging.
Main Results:
- A potassium double dose error occurred due to a packaging flaw.
- The flaw involved the dual expression of dosage (potassium salt and elemental potassium).
- This ambiguity in dosage units on the packaging was the primary trigger.
Conclusions:
- Packaging design is critical for safe medication use.
- Standardizing dosage units to millimoles (mmol) for both packaging and prescriptions can mitigate confusion.
- Implementing millimole standardization is a viable strategy to prevent medication errors like potassium double dosing.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Drug Dosing: Obese Patients
Dosage Regimens: Designs and Approaches
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Acute Kidney Injury V: Interprofessional Care
Drug Dosing: Infants and Children

